Exane Derivatives has filed its 13F form on July 12, 2022 for Q2 2022 where it was disclosed a total value porftolio of $157 Million distributed in 758 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $8.79M, Microsoft Corp with a value of $6.17M, Merck & Co., Inc. with a value of $5.92M, Cameco Corp with a value of $5.21M, and Ishares Inc Msci Global Select with a value of $3.52M.
Examining the 13F form we can see an decrease of $167M in the current position value, from $323M to 157M.
Also it can be appreciated an additional of 57 stocks purchases and 316 closed positions.
Below you can find more details about Exane Derivatives portfolio as well as his latest detailed transactions.
Portfolio value
$157 Million
ETFs: $28.2 Million
Technology: $25.8 Million
Healthcare: $20.9 Million
Energy: $19.3 Million
Industrials: $11.4 Million
Consumer Defensive: $10.7 Million
Financial Services: $10.4 Million
Consumer Cyclical: $10.2 Million
Other: $19.7 Million
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
